ATS MEDICAL INC 4
4 · ATS MEDICAL INC · Filed Aug 16, 2010
Insider Transaction Report
Form 4
ATS MEDICAL INCATSI
Transactions
- Disposition to Issuer
Warrant
2010-08-12$4.00/sh−94,953$379,812→ 0 total(indirect: Essex Woodlands Health Ventures Fund VIII-A, L.P.)Exercise: $2.85From: 2008-12-19Exp: 2015-12-19→ Common Stock (94,953 underlying) - Disposition to Issuer
Common Stock
2010-08-12−273,030→ 0 total(indirect: Essex Woodlands Health Ventures Fund VIII-B, L.P.) - Disposition to Issuer
Warrant
2010-08-12$4.00/sh−41,284$165,136→ 0 total(indirect: Essex Woodlands Health Ventures Fund VIII-B, L.P.)Exercise: $2.85From: 2008-12-19Exp: 2015-12-19→ Common Stock (41,284 underlying) - Disposition to Issuer
Common Stock
2010-08-12−8,709,641→ 0 total - Disposition to Issuer
Common Stock
2010-08-12−627,968→ 0 total(indirect: Essex Woodlands Health Ventures Fund VIII-A, L.P.) - Disposition to Issuer
Warrant
2010-08-12$4.00/sh−1,316,955$5,267,820→ 0 totalExercise: $2.85From: 2008-12-19Exp: 2015-12-19→ Common Stock (1,316,955 underlying)
Footnotes (4)
- [F1]In connection with the merger of a subsidiary of Medtronic, Inc. into Issuer on August 12, 2010 (the "Merger") pursuant to an agreement and plan of merger dated April 28, 2010, all shares of Issuer common stock were converted into the right to receive $4 per share in cash.
- [F2]The general partner of the reporting person beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of the pecuniary interest therein.
- [F3]This warrant was cancelled in the merger in exchange for the right to receive a cash payment equal to the product of (i) the total number of shares subject to the warrants, multiplied by (ii) the excess, if any, of $4 over the exercise price per share of the shares subject to the warrant, less any applicable withholding taxes.
- [F4]Warrants are exercisable at a price $2.475 per share during the first year, $2.85 per share during the second year, and $3.10 thereafter.